The Price of Global Health blog covers the complex world of drug pricing and addresses the impact of current events and trends in the global payer environment on value demonstration requirements, drug development needs and pricing decisions. When you subscribe, articles like these will be delivered straight to your inbox:
- The Hepatitis C Pricing Debate
- RIP Value-Based Pricing, Long Live Multi-Criteria Decision Analysis?
- New Edition: The Price of Global Health